Journal
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
Volume 25, Issue 1, Pages 75-89Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.beha.2012.01.005
Keywords
LMP-1; EBNA-1; Epstein-Barr virus; lymphoma; lymphoproliferative disorders; cytotoxic T-lymphocyte
Categories
Funding
- NIH
Ask authors/readers for more resources
Epstein-Barr virus (EBV) is a ubiquitous gamma-herpes virus that infects most people but results in life-threatening diseases in only a small subset. Persons who are unable to maintain the virus in its latent state can develop uncontrolled EBV-driven lymphoproliferative disorders and lymphomas. EBV-associated lymphomas are well characterized in patients with known defects in cellular immunity as occurs post-transplantation or HIV/AIDS but are increasingly recognized in patients without overt immunodeficiencies. Improved understanding of the biology of these lymphomas and the role EBV plays in lymphomagenesis offer the opportunity for improved therapies targeted at important signaling pathways and immunotherapy specific against EBV viral antigens. Published by Elsevier Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available